Oral Baclofen Expert Views

Dr. Bhooma Aravamuthan, a pediatric movement disorders neurologist, discusses the challenges in diagnosing and managing dystonia and spasticity in cerebral palsy. She explains the difference between rigidity and spasticity, noting that rigidity involves muscles staying tight regardless of movement speed, while spasticity tightens muscles more when stretched quickly. She highlights the importance of finding neurologists who can differentiate and manage these conditions. Regarding oral Baclofen, a muscle relaxer, a patient reported chest pain as a side effect, which improved after discontinuing the medication. Dr. Aravamuthan suggests exploring alternative treatments for muscle relaxation.

Alessandro Capuano discusses the management of dystonia in children and adolescents, focusing on factors that worsen the condition, such as infections and painful stimuli. He highlights the importance of recalibrating medications like oral Baclofen and dopamine receptor blockers in 67% of cases. Capuano also notes that intensive care unit admission is required in about 30% of severe cases. Additionally, he mentions stereotactic pallidotomy as a potential treatment for medically resistant cases.

The expert discussion highlights the use of oral Baclofen for managing spasticity in adults with cerebral palsy. Among the 47 participants studied, 21 were using oral Baclofen, and the research explored its effects on spasticity and pain. The study found statistical correlations between spasticity measures and pain interference scores, but some associations were weak in clinical significance. Age was linked to increased pain measurements, and spasticity levels varied with functional classification levels. The experts noted that the study group was small and treated at a single institution, which may limit generalizability. They suggested a larger, multi-site study to better understand the relationship between spasticity management and pain in cerebral palsy.